Coty vs LOréal: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Coty Inc (COTY)

Q3 20268 Jul – 20 Aug 2026

▼3▲1

Coty's Gucci Exit Brings Cash but Weak Outlook Sinks Shares

Gucci Exit Brings $400M Cash Coty ended its Gucci beauty license a year early, receiving $400 million from Kering. The money will cut debt and fund its core fragrance business. This removes a fading license but gives cash to invest, supporting the stock.
This is the period's biggest strategic event, directly affecting Coty's capital and future business.
Weak Q4 Profit and No Full-Year Forecast Coty reported a larger-than-expected quarterly loss and said fiscal 2027 will be a transition year. It gave no full-year outlook, citing a strategic review. Investors hate uncertainty, so the stock fell sharply.
This is the main reason the stock dropped 14.5% on August 20 and reflects real earnings weakness.
Sales Decline and Profit Plunge Fourth-quarter like-for-like revenue fell 1% and adjusted operating income plunged 31%. Coty's sellout is trailing the beauty category. This shows the core business is struggling, which pressures the stock.
These are the key operating metrics that reveal Coty's underlying performance problems.
Oil Spike and Middle East Tensions Raise Costs Renewed Middle East conflict pushed oil above $92 a barrel, raising freight and production costs. Coty also flagged uncertainty from oil and the region. Higher costs squeeze margins, a negative for the stock.
This external cost pressure is a recurring risk that directly impacts Coty's profitability.

July 20268 Jul – 20 Aug 2026

▼3▲1

Coty's Gucci Exit Brings Cash but Weak Outlook Sinks Shares

Gucci Exit Brings $400M Cash Coty ended its Gucci beauty license a year early, receiving $400 million from Kering. The money will cut debt and fund its core fragrance business. This removes a fading license but gives cash to invest, supporting the stock.
This is the period's biggest strategic event, directly affecting Coty's capital and future business.
Weak Q4 Profit and No Full-Year Forecast Coty reported a larger-than-expected quarterly loss and said fiscal 2027 will be a transition year. It gave no full-year outlook, citing a strategic review. Investors hate uncertainty, so the stock fell sharply.
This is the main reason the stock dropped 14.5% on August 20 and reflects real earnings weakness.
Sales Decline and Profit Plunge Fourth-quarter like-for-like revenue fell 1% and adjusted operating income plunged 31%. Coty's sellout is trailing the beauty category. This shows the core business is struggling, which pressures the stock.
These are the key operating metrics that reveal Coty's underlying performance problems.
Oil Spike and Middle East Tensions Raise Costs Renewed Middle East conflict pushed oil above $92 a barrel, raising freight and production costs. Coty also flagged uncertainty from oil and the region. Higher costs squeeze margins, a negative for the stock.
This external cost pressure is a recurring risk that directly impacts Coty's profitability.

Latest8 Jul – 20 Aug 2026

▼3▲1

Coty's Gucci Exit Brings Cash but Weak Outlook Sinks Shares

Gucci Exit Brings $400M Cash Coty ended its Gucci beauty license a year early, receiving $400 million from Kering. The money will cut debt and fund its core fragrance business. This removes a fading license but gives cash to invest, supporting the stock.
This is the period's biggest strategic event, directly affecting Coty's capital and future business.
Weak Q4 Profit and No Full-Year Forecast Coty reported a larger-than-expected quarterly loss and said fiscal 2027 will be a transition year. It gave no full-year outlook, citing a strategic review. Investors hate uncertainty, so the stock fell sharply.
This is the main reason the stock dropped 14.5% on August 20 and reflects real earnings weakness.
Sales Decline and Profit Plunge Fourth-quarter like-for-like revenue fell 1% and adjusted operating income plunged 31%. Coty's sellout is trailing the beauty category. This shows the core business is struggling, which pressures the stock.
These are the key operating metrics that reveal Coty's underlying performance problems.
Oil Spike and Middle East Tensions Raise Costs Renewed Middle East conflict pushed oil above $92 a barrel, raising freight and production costs. Coty also flagged uncertainty from oil and the region. Higher costs squeeze margins, a negative for the stock.
This external cost pressure is a recurring risk that directly impacts Coty's profitability.

LOréal S.A. (OR.PA)

Q3 202618 Jun – 30 Jul 2026

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.
This is the core earnings event that directly drives investor confidence and valuation.
Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.
It confirms the growth trend and shows demand is holding up in key regions.
Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.
It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.
Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.
These deals show management actively deploying capital for future growth.

July 202618 Jun – 30 Jul 2026

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.
This is the core earnings event that directly drives investor confidence and valuation.
Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.
It confirms the growth trend and shows demand is holding up in key regions.
Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.
It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.
Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.
These deals show management actively deploying capital for future growth.

Latest18 Jun – 30 Jul 2026

▲4

L'Oréal beats forecasts, buys growth, and adds Gucci beauty

H1 results beat expectations with record margin L'Oréal's first-half sales rose 6.5% like-for-like to €23.77bn, with a record 21.3% operating margin. All four divisions grew, led by Professional Products and Dermatological Beauty. Strong profit and broad-based growth support a higher share price.
This is the core earnings event that directly drives investor confidence and valuation.
Q2 sales beat forecasts on haircare and mascara demand Second-quarter like-for-like sales rose 6.3%, beating the 5.7% consensus, with Europe up 6.7% and North America up 5.9%. Luxury missed forecasts but China showed double-digit growth. The beat signals resilient consumer demand despite travel retail weakness.
It confirms the growth trend and shows demand is holding up in key regions.
Gucci beauty license starts early, expanding prestige portfolio Coty will exit its Gucci beauty license a year early, letting L'Oréal begin a 50-year exclusive license from July 2027. L'Oréal covers about 70% of Coty's early redemption costs. This adds a major luxury brand to its prestige lineup.
It is a new, long-term revenue stream that strengthens L'Oréal's luxury division.
Acquires Innovist in India and eyes Armani stake L'Oréal agreed to buy a majority stake in Indian digital-first personal care house Innovist, adding brands like Bare Anatomy. It is also named as a possible buyer of a stake in Giorgio Armani Group. Both moves expand reach in fast-growing markets and prestige.
These deals show management actively deploying capital for future growth.